• Title/Summary/Keyword: 저림감

Search Result 3, Processing Time 0.016 seconds

Tingling Sensation and Difficulty in Daily Living of Clients Treated FOLFOX Chemotherapy after Colon Resection (FOLFOX 항암화학요법을 받는 대상자의 저림감과 일상생활 어려움)

  • Lee, Hye-Seon;Kim, Myung-Hee;Kang, Eun-Hee
    • The Korean Journal of Rehabilitation Nursing
    • /
    • v.13 no.2
    • /
    • pp.97-104
    • /
    • 2010
  • Purpose: This study was to investigate difficulties in daily activities and tingling from patients having treatment of FOLFOX chemotherapy after colon resection. Method: This study included 103 patients hospitalized for FOLFOX chemotherapy in one of the university affiliated hospital from August 1, 2008 through September 30, 2009. Data were collected using the questionnaire comprised general symptoms, tingling, difficulties in daily activities and coping behavior. Using the SPSS 14.0 program, data analytic methods include Chi-Square test, ANOVA, Scheffe's test. Results: The tingling sensation occurred in hands, feet, mouth, throat. Contacts with cold objects and the number of chemotherapy cycle worsen tingling sensation. Patients experienced difficulties in daily activities such as personal hygiene, kitchen work, eating cold food, sleeping cold, using fine motors like button up, writing, or using knife. The coping behavior included drinking warm water, sleeping warm, using gloves and socks, wearing comfortable shoes, massaging hands and getting help from supporters. Conclusion: An educational guideline for promoting coping behavior to relieve tingling sensation and difficulty in daily living in patients with FOLFOX chemotherapy is needed.

칼슘차단제의 시판후 조사

  • 김영식;조홍준;최현림;서홍관;신호철;김경수;양윤준;김영주;조경환
    • Proceedings of the Korean Society of Applied Pharmacology
    • /
    • 1994.04a
    • /
    • pp.195-195
    • /
    • 1994
  • 병원별 총 추적기간은 602-4,137 인년 이었으며, 병원별 대상자 1인당 추적일수의 중앙값은 34.5-61일 이었다. 병원별 추적 완료율도 35.3-92.3%로 다양하게 나타났다. 대상자중 칼슘차단제의 혈관확장효과에 따른 부작용들의 8주간 누적 발생율을 보면, 안면홍조 23.3%, 두통 13.5%, 심계항진 13.3%, 어지러움 7.6%, 하지부종 6.6% 였다. 그 외 부작용으로는 변비 13예, 소화장애 8예, 오심 6예, 치은비대, 안면부종, 피로감이 각각 2예, 탈모증, 불면증, 허약감, 피부질환, 호흡곤란, 손발저림, 발한, 구강건조 등이 각각 1예 있었다. 안면홍조의 발생율이 남자(12.9%)보다 여자(29.9%)에서 높았으며, 투여한 약제에 따라서 Nitrendipine 34.0%, Nifedipine 26,6%, Nicardipine 17.8%, Amlodipine 12.2%로써 약제별로 차이가 있었다. 두통의 발생율은 40세 미만 32.8%, 40-54세 15,8%, 55세 이상 10.5%로써 연령이 증가할수록 발생율이 낮았다. 하지부종의 발생율도 남자(3.4%)보다 여자(8.6%)에서 높았으며, 투여한 약제에 따라서 Nitrendipine 15.2%, Nifedipine 10.0%, Amlodipine 2, 1%, Nicardipine 0%로써 약제별로 차이가 있었다. 안면홍조가 발생한 환자에서 약물을 계속 투여시 2주후에 63.5%, 4주후에 77.0% 6주후에 88.5%가 소실하여 최초 안면홍조가 발생한 환자중 11.5%에서만 증상이 남아있었다. 약물투여를 중단하게 된 사유는 안면홍조와 두통이 각각 15예, 심계항진 4예, 어지러움 2예, 변비 및 안면부종이 각각 1예로 나타났다.

  • PDF

A Case Study of a Taeeumin Patient with Paresthesia and Weakness in the Limbs of Unknown Cause Diagnosed as Dry-Heat (Joyeol) Pattern (태음인 조열병증(燥熱病證)으로 진단한 원인불명의 팔다리 저림 및 위약감 환자 치험 1례)

  • Lee, Mi-Suk;Bae, Na-Young
    • Journal of Sasang Constitutional Medicine
    • /
    • v.27 no.3
    • /
    • pp.346-355
    • /
    • 2015
  • Objectives The aim of this study was to report significant improvement of paresthesia and weakness in the limbs of unknown cause after treatment with Mangeummoonmu-tang and Cheongeummoonmu-tang in a Taeeumin patient. Methods The patient was diagnosed as Taeeumin Dry-Heat (Joyeol) pattern and treated with Mangeummoonmu-tang, Cheongeummoonmu-tang and acupuncture. The patient's subjective symptoms of paresthesia and weakness were observed using Global Assessment Scale (GAS) during the treatment period. Results and Conclusion The symptoms of paresthesia and weakness decreased from GAS 100 to GAS 0 for two weeks. Furthermore, the patient's symptoms of fatigue and xeroderma were reported to be improved after treatment. In conclusion, this study shows that Sasang constitutional medicine can be effective treatment for Taeeumin patient with paresthesia and weakness in the limbs of unknown cause.